These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 37444578)

  • 21. YAP/TAZ functions and their regulation at a glance.
    Pocaterra A; Romani P; Dupont S
    J Cell Sci; 2020 Jan; 133(2):. PubMed ID: 31996398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-Functional Regulation by YAP/TAZ Signaling Networks in Tumor Progression and Metastasis.
    Thrash HL; Pendergast AM
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the Hippo Pathway for Anti-cancer Therapies.
    Gong R; Yu FX
    Curr Med Chem; 2015; 22(35):4104-17. PubMed ID: 26429069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex.
    Kaan HYK; Chan SW; Tan SKJ; Guo F; Lim CJ; Hong W; Song H
    Sci Rep; 2017 May; 7(1):2035. PubMed ID: 28515457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a cryptic site at the interface 2 of TEAD - Towards a new family of YAP/TAZ-TEAD inhibitors.
    Sturbaut M; Bailly F; Coevoet M; Sileo P; Pugniere M; Liberelle M; Magnez R; Thuru X; Chartier-Harlin MC; Melnyk P; Gelin M; Allemand F; Guichou JF; Cotelle P
    Eur J Med Chem; 2021 Dec; 226():113835. PubMed ID: 34509860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia effects on glioblastoma progression through YAP/TAZ pathway regulation.
    Castillo C; Grieco M; D'Amone S; Lolli MG; Ursini O; Cortese B
    Cancer Lett; 2024 Apr; 588():216792. PubMed ID: 38453044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance.
    Hagenbeek TJ; Zbieg JR; Hafner M; Mroue R; Lacap JA; Sodir NM; Noland CL; Afghani S; Kishore A; Bhat KP; Yao X; Schmidt S; Clausen S; Steffek M; Lee W; Beroza P; Martin S; Lin E; Fong R; Di Lello P; Kubala MH; Yang MN; Lau JT; Chan E; Arrazate A; An L; Levy E; Lorenzo MN; Lee HJ; Pham TH; Modrusan Z; Zang R; Chen YC; Kabza M; Ahmed M; Li J; Chang MT; Maddalo D; Evangelista M; Ye X; Crawford JJ; Dey A
    Nat Cancer; 2023 Jun; 4(6):812-828. PubMed ID: 37277530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesothelioma.
    Papavassiliou KA; Sofianidi AA; Papavassiliou AG
    J Cell Mol Med; 2024 Apr; 28(8):e18330. PubMed ID: 38606782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
    Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
    Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of YAP/TAZ-TEAD activity induces cytotrophoblast differentiation into syncytiotrophoblast in human trophoblast.
    Mizutani T; Orisaka M; Miyazaki Y; Morichika R; Uesaka M; Miyamoto K; Yoshida Y
    Mol Hum Reprod; 2022 Sep; 28(10):. PubMed ID: 35993908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA SFTA1P mediates positive feedback regulation of the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer.
    Zhu B; Finch-Edmondson M; Leong KW; Zhang X; V M; Lin QXX; Lee Y; Ng WT; Guo H; Wan Y; Sudol M; DasGupta R
    Cell Death Discov; 2021 Nov; 7(1):369. PubMed ID: 34845189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hippo Signaling in Cancer: Lessons From
    Snigdha K; Gangwani KS; Lapalikar GV; Singh A; Kango-Singh M
    Front Cell Dev Biol; 2019; 7():85. PubMed ID: 31231648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy.
    Thompson BJ
    Bioessays; 2020 May; 42(5):e1900162. PubMed ID: 32128850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD.
    Kanai R; Norton E; Stern P; Hynes RO; Lamar JM
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis.
    Chen YA; Lu CY; Cheng TY; Pan SH; Chen HF; Chang NS
    Front Oncol; 2019; 9():60. PubMed ID: 30805310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis.
    Kim J; Kwon H; Shin YK; Song G; Lee T; Kim Y; Jeong W; Lee U; Zhang X; Nam G; Jeung HC; Kim W; Jho EH
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13529-13540. PubMed ID: 32482852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Real-Time PCR to Measure YAP/TAZ Activity in Human Cells.
    Cao X; Zhao B
    Methods Mol Biol; 2019; 1893():137-152. PubMed ID: 30565132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis.
    Islam R; Hong Z
    Mechanobiol Med; 2024 Dec; 2(4):. PubMed ID: 39281415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.